Emmanuelle Faure-Kumar - JoVE Visualize

Showing results (1-10 of 14) with videos related to

Pageof 2

Sort By:

F&S Science|August 17, 2022

Identification of miR-34-3p as a candidate follicular phase serum marker for endometriosis: a pilot studyWerner Maria Neuhausser, Emmanuelle Faure-Kumar, Swapna Mahurkar-Joshi, et al.

Journal of Virology|November 8, 2014

Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominanceOtto O Yang, Ayub Ali, Noriyuki Kasahara, et al.

Journal of the American Association for Laboratory Animal Science : JAALAS|March 31, 2016

Factors in the Selection of Surface Disinfectants for Use in a Laboratory Animal SettingMichael V Campagna, Emmanuelle Faure-Kumar, Janet A Treger, et al.

Journal of Biological Methods|January 25, 2020

Comparing NGS and NanoString platforms in peripheral blood mononuclear cell transcriptome profiling for advanced heart failure biomarker developmentGalyna Bondar, Wenjie Xu, David Elashoff, et al.

Journal of Visualized Experiments : Jove|March 19, 2019

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPRCarl Robert Rankin, Janet Treger, Emmanuelle Faure-Kumar, et al.

Human Gene Therapy|September 4, 2009

In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vectorShuji Kubo, Miho Kataoka, Chise Tateno, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007

Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccinesRichard C Koya, Takahiro Kimura, Antoni Ribas, et al.

Rheumatology International|June 27, 2023

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulinSangmee Sharon Bae, Emmanuelle Faure-Kumar, Kathie Ferbas, et al.

Clinical Transplants|August 7, 2014

Reduction of HLA class I expression by ribonucleic acid interference mitigates allogenicity of human primary and Immortalized cellsNathan A Lemp, Kazunori Haga, Katrin Hacke, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007

Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expressionTakahiro Kimura, Richard C Koya, Laura Anselmi, et al.

Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:

Pageof 2

F&S Science|August 17, 2022

Identification of miR-34-3p as a candidate follicular phase serum marker for endometriosis: a pilot studyWerner Maria Neuhausser, Emmanuelle Faure-Kumar, Swapna Mahurkar-Joshi, et al.

Journal of Virology|November 8, 2014

Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominanceOtto O Yang, Ayub Ali, Noriyuki Kasahara, et al.

Journal of the American Association for Laboratory Animal Science : JAALAS|March 31, 2016

Factors in the Selection of Surface Disinfectants for Use in a Laboratory Animal SettingMichael V Campagna, Emmanuelle Faure-Kumar, Janet A Treger, et al.

Journal of Biological Methods|January 25, 2020

Comparing NGS and NanoString platforms in peripheral blood mononuclear cell transcriptome profiling for advanced heart failure biomarker developmentGalyna Bondar, Wenjie Xu, David Elashoff, et al.

Journal of Visualized Experiments : Jove|March 19, 2019

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPRCarl Robert Rankin, Janet Treger, Emmanuelle Faure-Kumar, et al.

Human Gene Therapy|September 4, 2009

In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vectorShuji Kubo, Miho Kataoka, Chise Tateno, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007

Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccinesRichard C Koya, Takahiro Kimura, Antoni Ribas, et al.

Rheumatology International|June 27, 2023

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulinSangmee Sharon Bae, Emmanuelle Faure-Kumar, Kathie Ferbas, et al.

Clinical Transplants|August 7, 2014

Reduction of HLA class I expression by ribonucleic acid interference mitigates allogenicity of human primary and Immortalized cellsNathan A Lemp, Kazunori Haga, Katrin Hacke, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007

Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expressionTakahiro Kimura, Richard C Koya, Laura Anselmi, et al.

Pageof 2